Spring Bank Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. The company is engaged in the discovery and development of therapeutics using proprietary small molecule nucleic acid hybrid or SMNH, chemistry platform. These SMNH products can be used for the treatment of viral disease including hepatitis B virus.